We have shown that the intramuscular administration of RNase A or DNase I has a systemiceffect on malignant tumors, which is manifested as a retardation of tumor growth (RNase A), adecrease in the amount and area of metastases, and destructive changes in metastatic foci (bothenzymes). This evidence concerns the gene RNASE1 and cancer.